Page last updated: 2024-08-23

substance p and Sclerosis, Systemic

substance p has been researched along with Sclerosis, Systemic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertinotti, L; Casale, R; Colangelo, N; Del Rosso, A; Matucci-Cerinic, M; Pietrini, U; Zoppi, M1
Bény, JL; Marie, I1
Bertinotti, L; Casale, R; Cozzi, F; Del Rosso, A; Fanciullacci, M; Generini, S; Giacomelli, R; Matucci-Cerinic, M; Messori, A; Pietrini, U; Pignone, A; Sicuteri, R1
Brodecka, H; Glinska-Ferenz, M; Glinski, W; Kowalski, D1
Haustein, UF; Seikowski, K; Weber, B1
Akesson, A; Scheja, A; Sundler, F; Wallengren, J1
Cailes, J; du Bois, RM; Evans, TW; Winter, S1
Freedman, RR; Girgis, R; Mayes, MD1
Glinska-Ferenz, M; Glinski, W; Pierozynska-Dubowska, M1

Reviews

1 review(s) available for substance p and Sclerosis, Systemic

ArticleYear
The use of pupillometry in joint and connective tissue diseases.
    Annals of the New York Academy of Sciences, 2002, Volume: 966

    Topics: Autoimmune Diseases; Connective Tissue Diseases; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Humans; Joint Diseases; Neurotransmitter Agents; Parasympathetic Nervous System; Pupil Disorders; Reflex, Pupillary; Rheumatic Diseases; Scleroderma, Systemic; Sjogren's Syndrome; Substance P; Sympathetic Nervous System

2002

Trials

2 trial(s) available for substance p and Sclerosis, Systemic

ArticleYear
Pupillocynetic activity of substance P in systemic sclerosis.
    The Journal of rheumatology, 2003, Volume: 30, Issue:6

    Topics: Aged; Autoantibodies; Female; Humans; Iris; Male; Middle Aged; Neurons, Afferent; Pupil; Reflex, Pupillary; Scleroderma, Systemic; Substance P

2003
Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
    Chest, 1998, Volume: 114, Issue:1

    Topics: Adenosine; Adult; Capillaries; Cardiac Output; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Male; Microcirculation; Middle Aged; Prospective Studies; Pulmonary Circulation; Scleroderma, Systemic; Stroke Volume; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents

1998

Other Studies

6 other study(ies) available for substance p and Sclerosis, Systemic

ArticleYear
Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:6

    Topics: Acetylcholine; Adenosine Triphosphate; Animals; Aorta, Thoracic; Bradykinin; Calcium; Disease Models, Animal; Endothelium, Vascular; Iloprost; In Vitro Techniques; Isometric Contraction; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Confocal; Nitric Oxide; Nitric Oxide Synthase; Scleroderma, Systemic; Skin; Substance P; Vasodilation; Vasodilator Agents

2002
Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease.
    International journal of dermatology, 1994, Volume: 33, Issue:5

    Topics: beta-Endorphin; Capsaicin; Dermatitis, Atopic; Humans; Neuropeptides; Psoriasis; Scleroderma, Systemic; Skin; Substance P

1994
[Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995, Volume: 46, Issue:2

    Topics: Adolescent; Adult; Aged; Arousal; Autogenic Training; Female; Fingers; Humans; Male; Middle Aged; Raynaud Disease; Reference Values; Regional Blood Flow; Scleroderma, Systemic; Substance P; Vasoactive Intestinal Peptide

1995
Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosis.
    Acta dermato-venereologica, 1996, Volume: 76, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Calcitonin Gene-Related Peptide; Case-Control Studies; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nerve Fibers; Neuropeptide Y; Neuropeptides; Scleroderma, Systemic; Skin; Substance P; Vasoactive Intestinal Peptide

1996
Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
    The Journal of rheumatology, 2001, Volume: 28, Issue:1

    Topics: Blood Flow Velocity; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fingers; Humans; Male; Methacholine Chloride; Muscarinic Agonists; Nitroprusside; Raynaud Disease; Scleroderma, Systemic; Substance P; Vasodilator Agents

2001
Neurogenic inflammation induced by capsaicin in patients with psoriasis.
    Acta dermato-venereologica, 1991, Volume: 71, Issue:1

    Topics: Administration, Cutaneous; Adult; Age Factors; Capsaicin; Dose-Response Relationship, Drug; Erythema; Forearm; Humans; Inflammation; Psoriasis; Scleroderma, Systemic; Skin; Substance P

1991